(KNB ) stated it has established a EU-GMP manufacturing line for the group’s medical grade Hemp CBD line in partnership with CBD producer Pure Origin Group.
Pure Origin Group had initially created a devoted manufacturing line for Kanabo’s CBD Wellness formulation utilizing Kanabo’s tools, manufacturing protocols and IP in Could 2021.
Kanabo, which distributes cannabis-derived merchandise, stated it selected Pure Origin Group for its Good Manufacturing Practices (GMPs) to control manufacturing, verification and validation, making certain that its completed merchandise are ‘efficient and secure for market distribution.’
Kanabo stated that this manufacturing line marks the tip of its pilot gross sales and preludes a full product launch inside its major markets. In consequence, the group stated it can now embark on the second part of its gross sales plan to extend income from the sale of CBD merchandise.
Shares in Kanabo Group had been buying and selling 0.53% larger this morning to 19p following the information.
The pilot gross sales, which has lasted a interval of three months, has supplied a number of necessary efficiency measures in relation to the sale of Kanabo’s retail CBD merchandise within the UK.
“In a single month now we have succeeded in a joint effort with the Pure Origin staff to ascertain a EU-GMP manufacturing line for Kanabo’s medical grade Hemp CBD line. This manufacturing is a key achievement that may deliver a brand new high quality of medical CBD vape merchandise that weren’t beforehand obtainable on to the UK market,” stated Kanabo’s Chief Govt, Avihu Tamir.
Pure Origin’s Joint MD, Tony Rolfe, stated, “We’re delighted to companion with Kanabo within the run as much as full manufacturing and product launch of their EU-GMP manufactured CBD formulation.”
Comply with Information & Updates fromright here: